Type 2 diabetes mellitus without vascular complications and ischemia modified albumin

Clinical Laboratory

Volumn 56, Issue 5-6, 2010, Pages 187-190

  Dahiya, Kiran ^a,b   Aggarwal, Kavita ^b   Seth, Shashi ^a   Singh, Veena ^a   Sharma, Tarun K ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY   (India)

Author keywords

HbA1C; Ischemia modified albumin; Type 2 diabetes mellitus; Vascular complications

Indexed keywords

HEMOGLOBIN A1C; ISCHEMIA MODIFIED ALBUMIN;

ADULT; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; VASCULAR DISEASE;

ADULT; ALBUMINURIA; BLOOD PRESSURE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; REFERENCE VALUES; SERUM ALBUMIN; TRIGLYCERIDES;

EID: 77953313542     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. He XM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature 1992; 358: 209-15.
2. 2+ binding amino acid residues of the N-terminus of human albumin: an insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 2001; 268: 42-7. (Pubitemid 32054374)
3. Bar-Or D, Lau E, Rao N, Bampos N, Winkler JV, Curtis CG. Reduction in the cobalt binding capacity of human serum albumin with myocardial ischemia. Ann Emerg Med 1999; 34: 556.
4. Andrew Worster, P.J. Devereaux, Diane Heels-Ansdell, Gordon H. Guyatt, John Opie, Farouk Mookadam and Stephen A. Hill. Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. Can Med Assoc J 2005; 172: 1685-90.
5. Gunduz A, Turedi S, Mentese A, Altunayoglu V, Turan I, Krahan SC, et al. Ischemia- modified albumin levels in cerebrovascular accidents. Am J Emerg Med 2008; 26: 874-8.
6. Abboud H, Labreuche J, Meseguer E, Lavallee PC, Simon O, Olivot JM, et al. Ischemia modified albumin in acute stroke. Cerebrovasc Dis 2007; 23: 216-20. (Pubitemid 46239165)
7. Borderie D, Allanore Y, Meune C, Devaux JY, Ekindjian OG, Kahan A. High ischemia modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin Chem 2004; 50: 2190-3. (Pubitemid 39425871)
8. Cichota LC, Moresco RN, Duarte MM, Da Silva JE. Evaluation of ischemia- modified albumin in anemia associated to chronic kidney disease. J Clin Lab Anal 2008; 22: 1-5.
9. Zapico-Muniz E, Santalo-Bel M, Muntanola MJ, Montiel JA, Martinez- Rubio A, Ordonez- Llanos J. Ischemia-modified albumin during skeletal muscle ischemia. Clin Chem 2004; 50: 1063-5. (Pubitemid 38725798)
10. Van Rijn BB, Franx A, Sikkema JM, Van Rijn HJ, Bruise HW, Voorbij HA. Ischemia modified albumin in normal pregnancy and preeclampsia. Hypertens Pregnancy 2008; 27: 159-67. (Pubitemid 351892682)
11. Piwowar A, Knapik KM, Warwas M. Ischemia-modified albumin level in type 2 diabetes mellitus - Preliminary report. Dis Markers 2008; 24: 311-7.
12. Ukinc K, Eminagaoglu S, Ersoz HO, et al. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine 2009; Sep26 [Epub ahead of print].
13. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt albumin binding and its potential as a marker for myocardial ischemia - a preliminary report. J Emerg Med 2009; 19: 311-5.
14. Kumar A, Sivakanesan R, Singh S. Oxidative stress, endogenous antioxidant and ischemia modified albumin in normolipidemic acute myocardial infarction patients. J Health Sciences 2008; 54: 482-7.
15. DeFronzo RA. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 1997; 5: 177-269.